Elios Vision Announces Collaboration with the International Glaucoma Surgical Registry

Elios Vision has announced its collaboration and support for the International Glaucoma Surgical Registry (IGSR), an open access tool which enables surgeons to upload and analyze their data and compare outcomes with other centers. The IGSR was established more than 5 years ago and currently holds data for 7,000 procedures across 63 countries. In 2019, the IGSR became the official registry partner of the European Glaucoma society (EGS).

“We are delighted to collaborate with and support the objectives of the International Glaucoma Surgical Registry. Capturing long-term, real-world evidence is of high importance especially when adopting and integrating new surgical treatments. We hope the collaboration will encourage other surgeons to utilize the platform for audit and data generation purposes," Dr. Cameron Hudson, Senior Vice President OUS, Elios Vision, said in a company news release.

Elios Vision is a privately held medical device company focused on the commercialization of Elios, a novel MIGS technology used to treat glaucoma. Elios uses excimer laser energy to create microscopic openings (microchannels) in the trabecular meshwork to re-establish the natural flow of aqueous. 

Dr. Cameron Hudson - Senior Vice President OUS, Elios Vision, & Professor Keith Barton, co-founder of the IGSR with Dr Nathan Kerr